Heparan sulfate degradation was increased in the presence of overexpressed heparanase induced by tamoxifen treatment in ER positive breast cancer, which may be able to promote tumor invasion and therefore confer tamoxifen resistance (46). Here, HPSE is linked to breast cancer.